As MMP2, MT1-MMP (MMP14), and tissue inhibitor of MMP2 (TIMP2) were associated with aggressive tumor progression and low survival rates in several tumor types, Zhong et al. investigated their gene expression, protein activation inhibition, and regulation via signaling pathways in six human mesothelioma and one mesothelial cell line. This evidence concerns the gene MMP14 and neoplasm.